GSUN — Golden Sun Health Technology Income Statement
0.000.00%
Last trade - 00:00- $6.70m
- $10.26m
- $10.16m
Annual income statement for Golden Sun Health Technology, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.74 | 15 | 10.8 | 6.16 | 10.2 |
| Cost of Revenue | |||||
| Gross Profit | 3.66 | 8.82 | 4.81 | 1.79 | 2.36 |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | 7.68 | 13.1 | 12.4 | 12.3 | 12.7 |
| Operating Profit | 0.056 | 1.95 | -1.54 | -6.14 | -2.56 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.038 | 1.97 | -1.76 | -5.64 | -3.95 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.146 | 1.31 | -2.12 | -5.78 | -3.97 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 0.042 | 1.98 | -2.14 | -5.79 | -3.71 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.042 | 1.98 | -2.14 | -5.79 | -3.71 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.122 | 0.864 | -1.48 | -3.08 | -1.87 |
| Dividends per Share |